礼来豪掷270亿美元,在美打造四大生产基地,投资总规模创美国制药业新高

华尔街见闻
27 Feb

制药巨头礼来周三宣布,计划投资至少270亿美元在美国建设四个新的生产基地,以满足其畅销减肥药和糖尿病药物的旺盛需求,并支持其他疾病的新药研发。 此举使礼来近年在美制造业总投资超过500亿美元,创下美国制药史上最大规模的扩张投资。 周三,礼来盘中一度涨近2.3%。 填补供应链缺口,增强生产能力 礼来CEO David Ricks在华盛顿的一场活动中透露:"我们正进行这些投资...为我们预计未来各...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10